Document:

<PAGE>
                                 LEXXUS CAPITAL
                        405 Lexington Avenue, 47th Floor
                            New York, New York 10174
                                  212-972-3350

                              CONSULTING AGREEMENT
                              --------------------

This agreement ("Agreement") is entered into, this 14th day of May, 1999 between
Steroidogenesis Inhibitors, International ("Company") and Lexxus ("Consultant").

WHEREAS, Consultant has experience in corporate acquisitions, corporate finance,
financial public relations, and knowledge in the development of secondary
trading markets and

WHEREAS, the Company desires to engage Consultant to assist in raising capital
through the Public Markets, developing secondary trading markets for the
Company's securities, and for advice on financial public relations and
investment banking matters.

NOW THEREFORE, the Company and Consultant agree as follows:

1. CONSULTANT'S SERVICES

Consultant will provide the Company consulting service for one year in
connection with the following matters:

o Assist in compiling such financial information along with any other "due
  diligence" information that may be required to assist the Company in raising
  Equity Capital.
o Assist in raising capital for the purpose of implementing the Company's
  transitional and organizational business plan.
o Assume responsibility for communications and correspondence with brokers,
  money Managers, and Investors as it relates to corporate developments.
o Develop additional brokers relations program.
o Provide sponsorship for the Company at Regional Investment Banker Syndicate
  seminars and other Broker Dealer sponsorship meetings, as it is mutually
  agreeable between the Company and the Consultant.
o Consult with the Company about it's present and future securities structure.
o Provide additional guidelines regarding stock distribution and shareholder
  relations program.
o Assist in coordination of financial public relations, including the delivery
  of one CFA report to the Company.
o Assist in writing and/or editing all new announcements and vetting them to the
  shareholders, and appropriate wire services as well as the public at large.
o Participate in and coordinate road trips for Company executives to provide
  introductions and information to brokers, investment bankers, financial
  analysts, and money managers about the Company.
o Develop Broker Database followed by other "target" areas as considered
  beneficial by the Company.

<PAGE>

o Five Thousand dollars ($5,000.00) per month as a monthly retainer, payable in
  cash or free trading stock, at the option of the Company.
o A ten percent Consulting Fee for any financing provided in the Company, plus
  up to 3% in unaccountable expenses; or a five percent override for the
  introduction of Financing through a Broker or as Investment Banker. The 10 per
  cent commission can be paid in either cash or stock, or a combination thereof,
  as determined by the consultant.
o Reimbursement of expenses on a Pre-approved basis by the CEO.
o Reimbursement of reasonable out of pocket expenses incurred by Consultant in
  performance of the services contemplated by this Agreement.
o An incentive stock option, to be discussed as it relates to the Company's
  reporting status with the SEC; i.e. based on the current availability, while
  the Company is nonreporting and after fully reporting status is achieved.

3. INDEMNIFICATION

The Company agrees to indemnify and hold harmless Consultant and their agents
and employees against any losses, claims, damage or liabilities, joint or
several, to which Consultant or any other such person may become subject, under
the Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions, suits or proceedings in respect thereof) arise out of or are based upon
any untrue statement or alleged untrue statement of any material, or arising out
of or based upon the omission or alleged omission to state therein or necessary
to make the statements therein not misleading and will reimburse Consultant or
any such other person for any such legal or other expenses reasonably incurred
by Consultant or any such person in connection with investigation or defending
any such loss, claim, damage, liability or action, suit or proceeding provided,
however, that the Company will not be liable in any such case to the extent that
any such loss, claim damage or liability arises out of or is based upon an
untrue statement or alleged untrue statement in, or omission or alleged
omissions in reliance upon and in conformity with written information furnished
to the Company by Consultant specifically for use in preparations thereof. This
Indemnity agreement will be in addition to any liability which the Company may
otherwise have.

Consultant will indemnify and hold harmless the Company, each of it's directors,
each of it's officers, or persons, if any, who control the Company within the
meaning of the Act against any losses, claims, damages or liabilities to which
the Company or any such other person may become subject, under the Act or
otherwise, insofar as such losses, claims, damages, or liabilities to which the
Company or any such other person may become subject, under the Act or otherwise,
insofar as such losses, claims, damages, or liabilities (or actions, suits, or
proceedings in respect thereof) arise out of or are based upon any untrue
statement or alleged untrue statement of any material fact that may arise out of
or are based upon the omission to state therein a material fact that may arise
out of or are based upon the omission or the alleged omission to state therein
a material fact required to be stated therein or

<PAGE>

necessary to make the statement therein not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omissions in reliance upon and in conformity
with written information furnished in the Company by the Consultant specifically
for use in the preparation thereof and will reimburse any legal or other
expenses reasonably incurred by the Company or any such other person in
connection with investigating or defending any such loss, claim, damage,
liability, or action, suit or proceeding. This Indemnity Agreement will be in
addition to any liability which the Consultant might have.

Promptly after receipt by an indemnified party under this section of notice of
the commencement of any action, suit or proceeding, such indemnified party will,
if a claim in respect thereof is to be made against an indemnifying party under
this section, notify the indemnifying party of the commencement thereof: But the
omission to so notify the indemnifying party will not relieve it from any
liability which it may have to any indemnified party otherwise than under this
section. In any case such action, suit or proceeding is brought against any
indemnified party and it notifies the indemnifying party of the commencement
thereof, the indemnifying party will be entitled to participate therein, and to
the extent may wish jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel satisfactory to such
indemnified party, and after notice from the indemnifying party to such
indemnifying party will not be liable to such indemnified party under this
section for any legal or other expenses subsequently incurred by such
indemnified party in connection with the defense thereof other than reasonable
cost of investigation.

4. TERMINATION

This Agreement may be terminated by mutual agreement of the parties at any time
or by either party on thirty days written notice to the other party. The
provisions on Indemnification shall survive any termination of the Agreement by
either party.

5. COMPLETE AGREEMENT: MODIFICATION

This Agreement together with it's Exhibits, constitute the entire understanding
of the parties with respect to the matters it purports to cover, and no promise,
representation, or warranty other than those set out herein, shall be of any
force or effect. No modification or amendment of this Agreement shall be of any
force unless reduced to writing, signed by all of the record shareholders, and
deposited with the Corporation.

6. DESCRIPTIVE HEADINGS

The Descriptive Headings of this Agreement are for convenience only and shall
not control or affect the meaning or construction of any provision of this
Agreement.

<PAGE>

7. COUNTERPARTS

This Agreement may be executed in any number of counterparts, and each such
counterpart hereof shall be deemed to be an original instrument, but all such
counterparts together shall constitute but one Agreement.

8. GOVERNING LAW AND VENUE

The interpretation and construction of this Agreement shall be governed by the
laws of the state of New York for the contracts made and to be performed in New
York. All obligations under this Agreement to purchase or sell shares or to give
notices for performance will be in New York, New York.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
as of this date first set forth herein.

Company _____________________            Consultant: _______________________

By: _________________________            By: _______________________________

Date: _______________________            Date: _____________________________<PAGE>

                                                                   Exhibit 10.7

        This assignment is made by Dr. Alfred T. Sapse, M.D. residing at 3525
Leor Court, Las Vegas, Nevada 89121, ("ASSIGNOR") to Steroidogenesis Inhibitors
International, a corporation organized under the laws of the State of Nevada and
having an office at 101 Convention Center Drive, Suite 310, Las Vegas, Nevada
89109 ("ASSIGNEE").

         FOR ONE U.S. DOLLAR ($1.00) AND FOR OTHER GOOD AND VALUABLE
CONSIDERATION, the receipt of which is hereby acknowledged, ASSIGNOR does hereby
sell, assign and transfer to ASSIGNEE the entire right, title and interest,
together with all rights of priority, in and to my invention entitled CIRCADIAN
RHYTHM CORTISOL CHART AND METHODS OF USE, as described and/or claimed in an
application for patent of the United States of America, Serial No. ________. A
declaration for the application has been executed on ________________.
ASSIGNOR further does hereby sell, assign
and transfer to ASSIGNEE the entire right, title and interest, together with all
rights of priority, in and to ASSIGNOR'S invention as described and/or claimed
in any and all applications for patents based on the invention, including
divisionals, continuations, renewals, substitutes and reissues thereof, and all
rights of priority resulting from any of these patent applications, as well as
all foreign counterparts and extensions thereof, together with all patents
issuing on any of these applications for the full terms of all of the patents
which may be granted on the invention.

        ASSIGNOR HEREBY AUTHORIZES ASSIGNEE to make applications for, to
prosecute such applications, and to receive patents for the invention in the
United States and any foreign countries, in ASSIGNEE's name.

        ASSIGNOR HEREBY PROMISES AND AGREES that ASSIGNOR will execute or
procure any further necessary assurance of title to the invention and any
patents which may issue on the invention. ASSIGNOR will, at any time, upon the
request and without further consideration, but at the expense of ASSIGNEE,
deliver any testimony in any legal proceedings and execute all papers and do all
other things that may be necessary or desirable to perfect the title to the
invention, or any patents which may be granted therefor, in ASSIGNEE, its
successors, assigns, or other legal representatives. ASSIGNOR will, at any time,
upon the request and at the expense of ASSIGNEE, execute any continuations,
divisionals, reissues, or any other additional applications for patents for the
invention or any part or parts thereof and any patents issuing thereon are
hereby assigned to ASSIGNEE. ASSIGNOR will make all rightful oaths, and do all
lawful acts required for procuring and enforcing any of the patents, without
further compensation, but at the expense of ASSIGNEE, its successors, assigns or
other legal representatives.

        ASSIGNOR HEREBY AUTHORIZES AND REQUESTS the Commissioner of Patents and
Trademarks to issue any and all Letters Patent of the United States for the
invention, resulting from any of the aforesaid applications to the ASSIGNEE.

                                             Dr. Alfred T. Sapse, M.D., ASSIGNOR

                                     Page 1

<PAGE>

STATE OF NEVADA         :
                        :       SS:
COUNTY OF CLARK         :

        Before me personally appeared Dr. Alfred T. Sapse, M.D., to me known to
be the same person described in and who executed the foregoing instrument, and
acknowledged that he executed the same, of his own free will and for the
purposes set forth.

         Sworn to before me and subscribed in my presence this 15th of July,
1999.

                                                        Sarah H. Thompson
                                                        Notary Public

                                     Page 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}]]